These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7868152)

  • 61. [Recent advances in xenotransplantation].
    Jeffrey L; Platt MD
    Presse Med; 1992 Dec; 21(41):1932-8. PubMed ID: 1294943
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Histopathology of cardiac xenograft rejection in the pig-to-baboon model.
    Goddard MJ; Dunning J; Horsley Jo; Atkinson C; Pino-Chavez G; Wallwork J
    J Heart Lung Transplant; 2002 Apr; 21(4):474-84. PubMed ID: 11927225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
    Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
    Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection.
    Kirk AD; Heinle JS; Mault JR; Sanfilippo F
    Transplantation; 1993 Oct; 56(4):785-93. PubMed ID: 8212196
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.
    Sandrin MS; McKenzie IF
    Immunol Rev; 1994 Oct; 141():169-90. PubMed ID: 7532618
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.
    Holzknecht ZE; Coombes S; Blocher BA; Plummer TB; Bustos M; Lau CL; Davis RD; Platt JL
    Am J Pathol; 2001 Feb; 158(2):627-37. PubMed ID: 11159199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production.
    Dorling A; Delikouras A; Nohadani M; Polak J; Lechler RI
    Xenotransplantation; 1998 Feb; 5(1):84-92. PubMed ID: 9507738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model.
    Chong AS; Shen J; Xiao F; Blinder L; Wei L; Sankary H; Foster P; Williams J
    Transplantation; 1996 Jul; 62(1):90-6. PubMed ID: 8693552
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Xenotransplantation: the importance of the Galalpha1,3Gal epitope in hyperacute vascular rejection.
    Joziasse DH; Oriol R
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):403-18. PubMed ID: 10571028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glaxo/MRS Young Investigator Prize. Xenotransplantation: immune barriers beyond hyperacute rejection.
    Dorling A; Lechler RI
    Clin Sci (Lond); 1997 Dec; 93(6):493-505. PubMed ID: 9497785
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prospects for xenotransplantation of the kidney.
    Platt JL
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):284-91. PubMed ID: 9263672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
    Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
    J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Xenograft rejection--molecular mechanisms and therapeutic implications.
    Magee JC; Platt JL
    Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
    Cable DG; Hisamochi K; Schaff HV
    Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunology of xenotransplantation.
    Saadi S; Platt JL
    Life Sci; 1998; 62(5):365-87. PubMed ID: 9449228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histopathology of xenografts in pig to non-human primate discordant xenotransplantation.
    Shimizu A; Yamada K
    Clin Transplant; 2010 Jul; 24 Suppl 22():11-5. PubMed ID: 20590687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.